Hawthorne Health
Sponsors & CROs
Partners
Resources
For Patients
About Us
Share your protocol
Home› Sponsors & CROs› Case studies› Vaccines

Case study · Vaccines

101 participants in five weeks as a rescue site network

A Phase 3 vaccine program behind schedule brought Hawthorne in as a rescue partner. Six pharmacy-based community sites enrolled 101 participants across five weeks of active enrollment.

101participants enrolledAcross six community sites
5 weeksof active enrollmentFrom first site activation to enrollment close
14 daysfrom contract signature to first site activatedSite initiation visits ran close to the signature date
81%screen-to-enrollment rate101 enrolled of 124 screened
2,550candidates identifiedAcross pharmacy referral, community outreach, and centralized recruitment
100%of pharmacy partners recruitedAll six pharmacy partners distributed study information and referred patients
Screened124 
Enrolled10181% of the stage above
Screening yield. Recruitment identified 2,550 candidates across all channels in five weeks, and of the participants who reached screening, 81% went on to enroll.
Paid social34
Central recruitment campaign32
Recruitment partner19
Participant referral5
Pharmacy referral4
Lab partner3
Hawthorne website3
Randomizations by recruitment channel. No single channel carried more than about a third of the total, which is what kept enrollment moving when the pharmacy databases did not match the protocol criteria. 100 of the 101 enrolled participants were randomized.

The situation

The sponsor was behind on enrollment and needed additional capacity late in the study. Hawthorne was brought in as a rescue partner, which meant standing up six community sites against a timeline set by a study already in flight rather than by a normal start-up schedule.

Rescue work is a different problem from volume work. The sponsor was not buying our total capacity. They were buying how quickly that capacity could be pointed at their protocol. Sites were activated fourteen days after the contract was signed, with site initiation visits running close to the signature date.

What made it difficult

  • Activation was staggered rather than simultaneous, so sites came online across a window instead of on one date.
  • The inclusion and exclusion criteria did not map cleanly onto the pharmacy patient databases, so the pharmacy referral channel could not carry recruitment on its own.
  • Staffing had to be locked in against a timeline that moved while the study was running.

What we did

  • Placed coordinators on site full time at each location, functioning as site directors rather than visit-level coordinators, with direct authority over pharmacy and investigator teams.
  • Ran recruitment centrally across community outreach, digital, and pharmacy referral together, rather than leaving each site to source its own candidates.
  • Kept every pharmacy partner engaged in recruitment throughout, with weekly and in several cases daily contact.

Result

Six community sites enrolled 101 participants across five weeks of active enrollment, with 101 of 124 screened participants going on to enroll. Every pharmacy partner in the network contributed referrals.

The engagement also served as a full-scale test of the operating model. Three findings were carried straight into how the network is staffed and run: coordinators on site as site directors is now standard for pharmacy-embedded studies, investigational product handling is a distinct training module delivered before activation rather than during it, and site staffing moved from fully variable to a semi-fixed model so availability is locked before a study is awarded.

Figures are Hawthorne Health operational data for the study period, as of September 1, 2026. The sponsor is not identified under the terms of the clinical trial agreement.

Study at a glance

Sponsor
Global vaccine sponsor
Study
Phase 3 vaccine program
Phase
Phase 3
Therapeutic area
Vaccines
Delivery model
In person, at our community sites
Engagement
Rescue engagement
Hawthorne sites
6
Status
Enrollment closed

Timeline

Award to contract signature
5 weeks
Contract signature to first site activated
14 days
Active enrollment
5 weeks
Status
Enrollment closed

Evaluate the network

Send us your protocol.

We will come back with fit, coverage, and an approach for your study.

Share your protocol

More studies

  • Intake to report cut from 16 days to 7, in a post-approval REMS imaging program
  • 3,000 in-home echocardiograms, with two uninterpretable
  • 96% of visits in window across a below-the-knee cardiovascular program
All case studies

Evaluate the network for your study

Send us your protocol for a feasibility review.

We will come back with a clear view of fit, coverage, and a recommended delivery approach.

Share your protocolstudies@hawthornehealth.com

Let’s talk.

Hawthorne Health

Clinical research delivered in the communities where patients live and receive care.

(415) 343-2600info@hawthornehealth.com

Sponsors & CROs
OverviewCase StudiesCommunity Site NetworkAt-Home TrialsHybrid TrialsCapabilitiesTherapeutic ExpertiseInvestigator NetworkRecruitmentCoverage CheckQuality & ComplianceFAQ
Patients
Find a StudyResearch LocationsAbout Clinical ResearchWhat to ExpectYour Rights & SafetyRefer a FriendProvider Referrals
Partners
Become a Site PartnerBecome an InvestigatorLabcorp Collaboration
Company
Hawthorne StoryRecognitionLeadershipCareersNewsroomContact
Copyright © 2026 Hawthorne Health, Inc. | All Rights Reserved
PrivacyTerms